Pharmesis International Ltd. (SGX:BFK)

Pharmesis International Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15	18	3	3	3	7
Market Cap Growth	517.28%	573.89%	7.89%	-27.33%	-47.37%	32.56%
Enterprise Value	17	21	5	4	4	7
Last Close Price	0.47	0.57	0.10	0.11	0.15	0.28
PE Ratio	8.00	11.78	-	-	13.89	-
PS Ratio	1.17	1.44	0.32	0.26	0.31	0.69
PB Ratio	1.38	1.58	0.27	0.23	0.27	0.56
P/TBV Ratio	1.41	1.62	0.29	0.25	0.29	0.59
P/FCF Ratio	23.89	-	-	2.04	-	41.89
P/OCF Ratio	16.89	-	-	1.97	24.90	19.15
EV/Sales Ratio	1.34	1.67	0.56	0.42	0.40	0.78
EV/EBITDA Ratio	15.93	34.91	-	-	8.93	-
EV/EBIT Ratio	26.80	55.85	-	-	19.59	-
EV/FCF Ratio	27.43	-	-	3.34	-	47.32
Debt / Equity Ratio	0.26	0.26	0.31	0.29	0.28	0.27
Debt / EBITDA Ratio	2.66	4.12	-	-	5.89	-
Debt / FCF Ratio	4.59	-	-	2.61	-	20.53
Asset Turnover	0.84	0.67	0.50	0.53	0.57	0.51
Inventory Turnover	3.06	2.95	1.88	2.65	3.20	3.02
Quick Ratio	0.57	0.79	0.58	0.82	0.92	0.86
Current Ratio	1.07	1.06	1.09	1.12	1.21	1.14
Return on Equity (ROE)	18.14%	13.14%	-8.82%	-5.42%	3.33%	-9.57%
Return on Assets (ROA)	2.64%	1.25%	-1.90%	-1.66%	0.72%	-2.92%
Return on Capital (ROIC)	3.06%	1.70%	-2.42%	-2.10%	0.88%	-3.51%
Return on Capital Employed (ROCE)	5.90%	3.20%	-	-	1.70%	-
Earnings Yield	12.53%	8.49%	-34.12%	-27.61%	7.20%	-18.00%
FCF Yield	4.19%	-4.35%	-83.72%	49.05%	-5.71%	2.39%
Buyback Yield / Dilution	-14.12%	-13.08%	-14.85%	-	-	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.